Molecular Assemblies is a private biotech company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products.
Molecular Assemblies is enabling the next era in biotechnology through a completely new approach to DNA synthesis utilizing natural processes.
Molecular Assemblies was founded in 2013 and is based in San Diego, California.
Molecular Assemblies' patented enzymatic method, based on making DNA the way nature makes DNA, produces long, high quality, sequence-specific DNA reliably, affordably, and sustainable.
Molecular Assemblies have pioneered a two-step enzymatic DNA synthesis process that can deliver highly-pure, sequence-specific DNA on demand, without a template, and can scale to longer DNA sequences.
Molecular Assemblies' technology will enable the reading and writing of DNA for industries, including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics.
Molecular Assemblies is backed by Casdin Capital, Agilent Technologies, iSelect Fund, Cavendish Impact Capital Fund, DCVC, SynBio Innovation Accelerator, Argonautic Ventures, Eleven Two Capital, and others. The company raised $25.8M in Series B round on Mar 15, 2022. This brings Molecular Assemblies' total funding to $87M to date.